News

A new national study led by Samantha X. Y. Wang, MD, sets out to understand exactly how language influences public attitudes toward health equity.

Stanford AI in Healthcare Leadership and Strategy: from Innovation to Implementation is a four-week hybrid experience designed for the people responsible for turning AI ideas into real-world impact.

We’re incredibly excited to share that Tariro Makadzange, MD, DPhil, Clinical Assistant Professor of Infectious Diseases at Stanford Department of Medicine, has been named to TIME's 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

Pascal’s research has driven some of the most impactful health discoveries of 2025. His widely covered work showing that shingles vaccination is associated with reduced dementia risk has captured global attention, changing the way we think about healthcare.

Robert Negrin is marking an extraordinary 2025-26, with major leadership roles, multiple lifetime achievement awards, and renewed NIH funding for Stanford’s BMT-CT program. The longtime physician-scientist is being recognized worldwide for his impact in research, mentoring future leaders, and translating discovery into patient care.

Artificial intelligence is no longer a speculative force in medicine. It is already embedded in everyday care. AI systems flag hospitalized patients at risk of deterioration, assist radiologists reading mammograms, draft clinicians’ notes, route patient messages, and increasingly interact directly with patients through chatbots and digital assistants.

As the popularity of Ozempic, Wegovy, and other GLP-1 receptor agonists skyrockets, so too do the questions surrounding their safety. Initially designed to treat type 2 diabetes, GLP-1 drugs are known to alter body composition, reducing fat mass but also affecting lean muscle. In the ICU, where patients already experience severe metabolic stress and muscle breakdown, clinicians have worried that these medications might quietly worsen outcomes.

A Stanford-led trial shows that a five-day-a-month fasting-mimicking diet may reduce symptoms and inflammation in adults with mild to moderate Crohn’s disease.

Infectious disease expert Marc Lipsitch reflects on pandemic lessons, science communication, and his next chapter at Stanford.

Stanford’s Division of Computational Medicine launches a new identity, showcasing its data-driven tools, AI innovation, and impact on clinical care.